Skip to main content

and
  1. Article

    Open Access

    Phenotypes and outcome of diffuse pulmonary non-amyloid light chain deposition disease

    Light chain deposition disease (LCDD) is a very rare entity. Clinical manifestations of LCDD vary according to the organs involved. Data on pulmonary LCDD are scarce and limited to small series or case reports...

    François Lestelle, Catherine Beigelman, David Rotzinger in Respiratory Research (2024)

  2. Article

    Open Access

    Role of the occupational disease consultant in the multidisciplinary discussion of interstitial lung diseases

    Diffuse interstitial lung diseases (ILD) constitute a heterogeneous group of conditions with complex etiological diagnoses requiring a multidisciplinary approach. Much is still unknown about them, particularly...

    Ségolene Carlier, Mouhamad Nasser, Emmanuel Fort, Céline Lamouroux in Respiratory Research (2022)

  3. Article

    Open Access

    Automatic quantitative computed tomography measurement of longitudinal lung volume loss in interstitial lung diseases

    To compare the lung CT volume (CTvol) and pulmonary function tests in an interstitial lung disease (ILD) population. Then to evaluate the CTvol loss between idiopathic pulmonary fibrosis (IPF) and non-IPF and exp...

    Salim A. Si-Mohamed, Mouhamad Nasser, Marion Colevray in European Radiology (2022)

  4. Article

    Open Access

    Nintedanib in idiopathic and secondary pleuroparenchymal fibroelastosis

    Pleuroparenchymal fibroelastosis (PPFE) has a variable disease course with dismal prognosis in the majority of patients with no validated drug therapy. This study is to evaluate the effect of nintedanib in pat...

    Mouhamad Nasser, Salim Si-Mohamed, Ségolène Turquier in Orphanet Journal of Rare Diseases (2021)

  5. Article

    Open Access

    Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study)

    There is a paucity of data on the epidemiology, survival estimates and healthcare resource utilisation and associated costs of patients with progressive fibrosing interstitial lung disease (PF-ILD) in France. ...

    Mouhamad Nasser, Sophie Larrieu, Loic Boussel, Salim Si-Mohamed in Respiratory Research (2021)

  6. Article

    Open Access

    Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey

    Some patients with interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis exhibit a progressive clinical phenotype. These chronic progressive fibrosing ILDs have a variety of underlying dis...

    Amy Olson, Nadine Hartmann, Padmaja Patnaik, Laura Wallace in Advances in Therapy (2021)